Skip to main content
    T

    TuHURA Biosciences Inc (HURA)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.33
    -0.06 (-4.32%)

    Market Cap: $88.58M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    29%(8/28)
    Avg Surprise
    -58.95%
    Streak
    2 Q

    Upcoming Estimates

    Reports Mar 29, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.14
    Range-$0.16 - -$0.13
    7 analysts
    Revenue Consensus
    N/A
    RangeN/A
    5 analysts

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-161.40%ROIC-81.75%
    Financial Health
    Debt/Equity0.50xInterest Coverage-26.32x
    Current Ratio0.47xQuick Ratio0.47x
    Trading Statistics
    Beta-0.74Avg Volume559.37K
    52-Week High$3.4352-Week Low$0.41

    Technical Indicators Dashboard

    As of Nov 16, 2026, the price is 30.1% below its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 30.1, in the neutral range between 30 and 70.

    Moving Averages

    SMA 10$1.55
    SMA 20$1.77
    SMA 50$1.90
    SMA 200$2.02
    EMA 10$1.54
    EMA 20$1.68
    EMA 50$1.86
    EMA 200$2.05

    MACD

    Line: -0.15Signal: -0.10Hist: -0.04

    ADX

    ADX: 26.4+DI: 10.0-DI: 29.6

    Aroon & PSAR

    Aroon Up40.0
    Aroon Down100.0
    PSAR$1.76

    Bollinger Bands

    Upper Band$2.29
    Lower Band$1.24
    %B Position5958%(Upper)
    Band Width0.08

    RSI (14-Day)

    Neutral
    30.1

    Momentum Oscillators

    Stoch %K7.0
    Stoch %D6.0
    Williams %R-92.4
    ROC (10d)-22.7%
    Momentum-0.39
    CCI (20d)-136.4
    MFI (14d)10.2

    Volatility Measures

    ATR (14d)$0.16(12.3%)
    StdDev (20d)0.26
    Hist Vol107.2%(High)

    Volume Flow

    VWAP$1.35
    OBV-16.9M
    AD Line-5.7M
    CMF (20d)-0.129

    Volume Metrics

    Avg Vol (20d)578.7K
    Vol Ratio2.3x(High)
    VWMA (20d)$1.77

    Pivot Points

    R3$1.66
    R2$1.59
    R1$1.49
    Pivot Point$1.43
    S1$1.32
    S2$1.26
    S3$1.16

    Advanced Oscillators

    TSI-25.57
    Ultimate Osc28.4
    KST-181.11

    Financial Performance

    Related GNG Research

    No research available

    Be the first to write about HURA

    News

    HURA Valuation

    HURA Profitability: Margins, ROIC and FCF

    TuHURA Biosciences (HURA) has an operating margin of 0.0% and a net margin of 0.0%. It posts -81.8% ROIC.

    Operating margin
    0.0%
    Net margin
    0.0%
    ROIC
    -81.8%
    ROE
    -161.4%
    HURA financial statements

    TuHURA Biosciences Competitors

    The companies most similar to TuHURA Biosciences (HURA) include Zura Bio Limited Class A Ordinary Shares, Coherus BioSciences and Humacyte.

    Sector: Healthcare

    Companies most similar to TuHURA Biosciences

    HURA Analyst Ratings

    TuHURA Biosciences (HURA) has a Buy consensus from 4 analysts: 4 Buy or Strong Buy, 0 Hold and 0 Sell or Strong Sell.

    Consensus
    Buy
    Analysts
    4
    Strong Buy
    2
    Buy
    2
    Hold
    0
    Sell
    0
    Strong Sell
    0
    HURA stock forecast

    HURA Earnings: Beat Rate and Next Report

    TuHURA Biosciences (HURA) beat the EPS estimate in 4 of the last 8 quarters (50.0%). Its next report is expected on Mar 29, 2027.

    Beat rate
    4 of 8 quarters (50.0%)
    Average surprise
    -1.6%
    EPS estimate (fiscal period ending Dec 31, 2026)
    -$0.14
    HURA earnings history

    HURA Earnings Date

    HURA reports Mar 29, 2027. The date is estimated.

    Updated Nov 14, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology

    Frequently Asked Questions About HURA

    When does HURA report earnings?

    TuHURA Biosciences Inc (HURA) is expected to report earnings on Mar 29, 2027.

    Does HURA pay dividends?

    TuHURA Biosciences Inc (HURA) does not currently pay a regular dividend.

    What is HURA's market cap?

    TuHURA Biosciences Inc (HURA) has a market capitalization of $88.58M with a current stock price of $1.33.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.